Roux-en-Y gastric bypass resolves type 2 diabetes in 76.8% of patients within one year. The procedure also resolves obstructive sleep apnea in 86% of cases according to a study of over a thousand patients. This article details the full spectrum of outcomes, from sustained weight loss and comorbidity remission to the risks of nutritional deficiencies and reoperation.
Key Takeaways
- RYGB resolves type 2 diabetes in 76.8% of patients at 1 year (meta-analysis of 45 studies)
- Hypertension remission in 61.7% post-RYGB at long-term follow-up
- Obstructive sleep apnea (OSA) resolution: 86% after RYGB (n=1,030)
- 10-year RYGB weight regain <10% in 65% with follow-up
- Nutritional deficiency: iron 30%, B12 27%, folate 15% at 5 years post-RYGB
- Reoperation rate 7.5% at 7 years for complications
- Laparoscopic RYGB operative time averages 120-150 minutes in high-volume centers
- Typical RYGB pouch size is 15-30 mL, biliopancreatic limb 30-50 cm, Roux limb 75-150 cm
- Hospital length of stay post-laparoscopic RYGB is 2.1 days (n=104,876)
- 30-day mortality for RYGB is 0.31% based on 104,876 ASMBS cases
- Major complication rate post-RYGB is 4.1% in MBSAQIP database (n=57,425)
- Leak rate after RYGB is 0.8-2.1% in large series
- In a prospective study of 2,487 patients undergoing Roux-en-Y gastric bypass (RYGB), the mean excess weight loss (EWL) was 72.4% at 1 year, 68.9% at 2 years, and 65.2% at 3 years post-surgery
- A meta-analysis of 36,000 RYGB patients reported average EWL of 55-75% sustained over 5 years, with 80% of patients maintaining >50% EWL at 10 years
- In the Swedish Obese Subjects study, RYGB patients lost 25% of total body weight at 2 years compared to 2% in controls
Roux-en-Y gastric bypass often achieves durable remission of major metabolic conditions and substantial weight loss.
Related reading
01 · Category
Comorbidity Resolution27 stats
01
RYGB resolves type 2 diabetes in 76.8% of patients at 1 year (meta-analysis of 45 studies)
02
Hypertension remission in 61.7% post-RYGB at long-term follow-up
03
Obstructive sleep apnea (OSA) resolution: 86% after RYGB (n=1,030)
04
Dyslipidemia improvement in 70% of RYGB patients at 2 years
05
GERD symptoms resolve in 70-90% post-RYGB
06
NAFLD steatosis reversal in 85% at 1 year post-RYGB
07
Asthma improvement in 67% of patients (n=199)
08
PCOS symptoms remit in 55% post-RYGB
09
Depression scores improve by 40% at 1 year (SOS study)
10
Venous stasis ulcers heal in 95% post-weight loss
11
Migraine frequency reduces by 50% in 81% of patients
12
Urinary incontinence resolves in 49% of women post-RYGB
13
GERD de novo in 15% but overall improvement 70%
14
Hyperuricemia normalizes in 62% at 12 months
15
Metabolic syndrome resolves in 82% post-RYGB
16
Chronic kidney disease progression slows by 30%
17
Pseudotumor cerebri resolves in 96% (n=25)
18
Steatohepatitis improves histologically in 90%
19
Endometrial hyperplasia regresses in 77%
20
Joint pain reduces in 73% at 1 year
21
Insulin resistance HOMA-IR drops 70% post-RYGB
22
Cardiovascular risk score decreases by 50% at 5 years
23
Fatty liver disease NASH resolution 84%
24
Hypogonadism improves in 60% of men
25
GERD medication use drops 83%
26
Diabetes remission durable in 50% at 5 years
27
OSA AHI reduces from 50 to 15 events/hour
Interpretation
Comorbidity Resolution Interpretation
Looking at this cascade of data, it becomes almost comically clear that gastric bypass isn't merely a weight-loss procedure but a master key that, in the majority of patients, unlocks a startlingly broad and profound reversal of modern metabolic misery.
02 · Category
Long-term Outcomes24 stats
01
10-year RYGB weight regain <10% in 65% with follow-up
02
Nutritional deficiency: iron 30%, B12 27%, folate 15% at 5 years post-RYGB
03
Reoperation rate 7.5% at 7 years for complications
04
Diabetes relapse 20-30% at 5 years despite initial remission
05
Mortality reduction 40% vs non-surgical obese at 10 years (SOS)
06
Bone mineral density loss 10-15% at spine after 2 years
07
Suicide risk 2-fold higher post-bariatric surgery
08
Revision rate for weight regain 10% at 8 years
09
Lifetime cost savings $20,000per patient vs medical management
10
Cancer risk reduction breast 20%, colon 40% post-RYGB
11
Pregnancy outcomes: macrosomia reduced to 5% post-RYGB
12
Alcohol use disorder increases 2.5-fold after 2 years
13
Quality-adjusted life years gained 4.3 per patient
14
Hypoglycemia incidence 1-5% long-term post-RYGB
15
Hair loss transient in 50% peaking at 4 months
16
20-year all-cause mortality HR 0.47 vs controls
17
Vitamin D deficiency 50% requiring 50,000 IU/week lifelong
18
Internal hernia reoperation 3.1% at 12 years
19
Employment rate increases 20% at 4 years follow-up
20
GFR decline slowed, ESRD risk reduced 32%
21
Dumping syndrome chronic in 15%
22
Fracture risk increases 2-fold after 5 years
23
SF-36 quality of life scores +25% sustained at 10 years
24
Small bowel obstruction 5% lifetime risk
Interpretation
Long-term Outcomes Interpretation
Gastric bypass offers a dramatic and potentially lifesaving trade, swapping a larger body for a smaller one that demands meticulous, lifelong upkeep and grapples with a new spectrum of risks, all while generally tipping the long-term scales toward profound health and longevity.
03 · Category
Procedure Details23 stats
01
Laparoscopic RYGB operative time averages 120-150 minutes in high-volume centers
02
Typical RYGB pouch size is 15-30 mL, biliopancreatic limb 30-50 cm, Roux limb 75-150 cm
03
Hospital length of stay post-laparoscopic RYGB is 2.1 days (n=104,876)
04
Hand-sewn vs stapled anastomosis: similar leak rates 1.1% vs 1.0%
05
Mesenteric defect closure reduces internal hernia to 1.7% vs 8.6%
06
Antecolic vs retrocolic Roux: antecolic preferred, lower obstruction 0.5%
07
Band-first technique used in 5% of RYGB for high-risk
08
Linear stapler 60mm used for 95% of gastrojejunostomies
09
Intraoperative leak test positive in 2.5%, managed conservatively 80%
10
Robotic RYGB: 3.5% complication vs 4.1% laparoscopic
11
Surgeon volume >100/year reduces complications to 3.2%
12
Single anastomosis duodenal switch variant in 10% of practices
13
5-port technique standard in 85% laparoscopic RYGB
14
Liver biopsy taken in 20% during RYGB for NAFLD staging
15
Drain placement in 30% of cases, removed day 1-2
16
Calibration with 20Fr bougie for pouch sizing in 90%
17
Prophylactic methylene blue test sensitivity 78% for leaks
18
Hand-assisted laparoscopic RYGB in 2% for difficult cases
19
Roux limb measurement laparoscopic vs open similar accuracy 95%
20
Postoperative ERAS protocol shortens LOS to 1.5 days in 70%
21
Staple line reinforcement used in 25% gastrojejunostomy
22
Critical view of Sugita applied in RYGB for safe dissection
23
Frozen section for gastric remnant malignancy in 0.1%
Interpretation
Procedure Details Interpretation
The modern gastric bypass is a masterclass in surgical precision, where saving minutes and millimeters—from a stapled pouch smaller than a shot glass to a strategically measured Roux limb—statistically stacks the deck in the patient's favor, proving that in high-volume hands, the devil and the safety are both in the meticulously documented details.
More related reading
04 · Category
Surgical Risks25 stats
01
30-day mortality for RYGB is 0.31% based on 104,876 ASMBS cases
02
Major complication rate post-RYGB is 4.1% in MBSAQIP database (n=57,425)
03
Leak rate after RYGB is 0.8-2.1% in large series
04
Bleeding requiring transfusion occurs in 1.5% of RYGB patients
05
Venous thromboembolism (VTE) prophylaxis reduces PE rate to 0.42% post-RYGB
06
Stricture rate at gastrojejunostomy is 3.5% within 30 days
07
90-day readmission rate is 5.7% for RYGB (MBSAQIP n=160,790)
08
Wound infection rate is 2.3% in laparoscopic RYGB series
09
Internal hernia risk post-RYGB is 2.5% at 5 years without closure
10
Conversion to open surgery rate is 0.2% in experienced centers
11
Myocardial infarction within 30 days: 0.13% post-RYGB
12
Pneumonia rate post-RYGB is 0.5%
13
Renal failure requiring dialysis: 0.1% in 30 days
14
Cerebrovascular accident rate: 0.04% perioperatively
15
Reoperation rate within 30 days: 2.7% for RYGB
16
Sepsis rate: 0.6% post-RYGB in NSQIP data
17
Bowel obstruction incidence: 1.8% at 1 year
18
Marginal ulcer rate: 5% at 2 years post-RYGB
19
Port site hernia: 1.2% in laparoscopic series
20
Splenic injury: 0.3% during RYGB
21
30-day morbidity: 10.3% in high-volume centers
22
Anastomotic stenosis: 4.2% treated endoscopically
23
DVT rate: 0.52% with prophylaxis
24
Postoperative ileus: 0.9%
25
Pancreatitis: 0.2% post-RYGB
Interpretation
Surgical Risks Interpretation
While the odds are overwhelmingly in your favor, undergoing gastric bypass is a bit like agreeing to a meticulously planned heist on your own anatomy—the statistics show the operation is remarkably safe, but the sheer list of potential complications reads like a darkly comedic catalog of everything that could possibly go wrong with a human body.
05 · Category
Weight Loss Efficacy30 stats
01
In a prospective study of 2,487 patients undergoing Roux-en-Y gastric bypass (RYGB), the mean excess weight loss (EWL) was 72.4% at 1 year, 68.9% at 2 years, and 65.2% at 3 years post-surgery
02
A meta-analysis of 36,000 RYGB patients reported average EWL of 55-75% sustained over 5 years, with 80% of patients maintaining >50% EWL at 10 years
03
In the Swedish Obese Subjects study, RYGB patients lost 25% of total body weight at 2 years compared to 2% in controls
04
Longitudinal data from 1,511 patients showed 68% EWL at 5 years post-RYGB, with super-obese patients achieving 62% EWL
05
ASMBS estimates average weight loss of 60-80% excess weight within 12-18 months after RYGB
06
A cohort of 4,047 patients had median EWL of 69.1% at 12 months post-RYGB
07
In 10-year follow-up of 165 patients, mean EWL was 51% post-RYGB, with 72% maintaining >40% EWL
08
Multicenter trial (n=200) reported 74.6% EWL at 1 year and 61.3% at 5 years for RYGB
09
UK National Bariatric Surgery Registry data: 70.5% EWL at 1 year for 7,714 RYGB cases
10
Study of 1,028 patients showed 64.3% total weight loss at 2 years post-RYGB
11
In adolescents (n=242), RYGB led to 58% EWL at 5 years
12
Veterans Affairs cohort (n=398) had 50.4% EWL at 6 years post-RYGB
13
Meta-analysis (88 studies, 160,000 patients) found RYGB EWL 59.7% at long-term follow-up
14
SOS study 20-year data: RYGB patients lost 18% body weight vs 2.2% in controls
15
Single-center experience (n=3,269): 73% EWL at 1 year, 62% at 5 years
16
Randomized trial vs sleeve: RYGB 69% EWL vs 62% at 3 years
17
Bariatric Outcomes Longitudinal Database: 67.8% EWL at 1 year for RYGB
18
15-year follow-up (n=88): mean BMI reduction from 48 to 32 kg/m² post-RYGB
19
IFSo global survey: average 65% EWL at 2 years across 42 countries
20
Michigan Bariatric Surgery Collaborative: 71% EWL at 1 year (n=17,232)
21
In super-super obese, RYGB achieved 57% EWL at 5 years (n=103)
22
Dutch audit (n=4,518): 68% EWL at 1 year post-RYGB
23
30-day readmission linked to 65% EWL at 1 year in 11,803 patients
24
Longitudinal Assessment of Bariatric Surgery: 58% EWL at 3 years (n=2,000+)
25
Scandinavian registry: 66% EWL at 2 years for 7,925 RYGB
26
Meta-analysis of revisional RYGB: 55% EWL at 2 years post-revision
27
Cleveland Clinic data: 72% EWL at 18 months (n=1,400)
28
10-year EWL plateau at 60% in 340 patients
29
BOLD database: 66.7% EWL at 12 months (n=57,467)
30
European registry: 67% EWL at 1 year for 18,317 RYGB
Interpretation
Weight Loss Efficacy Interpretation
The data shows that while the Roux-en-Y gastric bypass is a remarkably effective tool for substantial and sustained weight loss, it is not a magic wand, as the numbers reveal a very human story of initial dramatic success followed by a gentle, almost predictable, tapering off over the years.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Diana Reeves. (2026, February 13). Gastric Bypass Statistics. Gitnux. https://gitnux.org/gastric-bypass-statistics
MLA
Diana Reeves. "Gastric Bypass Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/gastric-bypass-statistics.
Chicago
Diana Reeves. 2026. "Gastric Bypass Statistics." Gitnux. https://gitnux.org/gastric-bypass-statistics.
Sources & references
3 datasets cited across this report · attribution is report-level